A Study of Single Dose of LP-003 in Healthy Adult Subjects

Clinical trial NCT06604949 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06604949
Sponsor: Longbio Pharma
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2024-10-23
Primary completion: 2026-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.